期刊文献+

“今又生”瘤体内注射联合化疗治疗肺癌颈部淋巴结转移的护理 被引量:6

"今又生"瘤体内注射联合化疗治疗肺癌颈部淋巴结转移的护理
下载PDF
导出
摘要 目的探讨"今又生"(重组人p53腺病毒)瘤内注射治疗肺癌颈部淋巴结转移的护理要点。方法对30例经病理组织学或细胞学确诊的肺癌颈部淋巴结转移患者实施瘤内注射"今又生",并联合全身化疗。治疗前与患者充分沟通,消除恐惧心理,告知可能出现的不良反应。操作时严格遵守无菌操作规程,配合医生进行瘤组织局部多点注射,注射后加强床边巡视,密切观察注射局部皮肤反应,密切监测体温变化,及时配合医生给予对症处理。结果患者均顺利、安全完成治疗,部分患者出现不良反应,经科学治疗、护理后均缓解。结论 "今又生"瘤内注射联合化疗对肺癌颈部肿块转移患者是安全、有效的方法,为我们在瘤内注射的护理方法上提供了一定的临床经验。
出处 《护士进修杂志》 北大核心 2011年第14期1326-1327,共2页 Journal of Nurses Training
关键词 瘤内注射 化疗 肺癌 护理 Intratumorally injection Chemotherapy Lung cancer Nursing
  • 相关文献

参考文献7

  • 1Swishers G, Rothj A. Clinical update of Ad-p53 gene therapy for lung cancer[J].J Am Surg Oncol Clin, 2002,11 (30) : 521- 535.
  • 2Roth J,Grammer SF. Gene replacement therapy for non-small cell lung cancer:a review[J]. Hematol Oncol Clin North Am, 2004,18(1) : 225-229.
  • 3Osaki S, Nakanishi Y, Takayama K, et al. Alteration of drug chemosenisitivity caused by the adenovirus-mediated transfer of the wild-type p53 gene in human lung eancer[J]. Cancer Gene Ther, 2000,7 (2) : 300-307.
  • 4Benianin R,choi H, Macapinlac H, et al. We should desist using RECIST, at least in GIS[J]. J Clin Oneol, 2007,25 (13) : 1760- 1764.
  • 5Swisher SG, Roth JA, Kamaki R, et al. Introduction of p53- requlated genes and tumor regression in lung cancer patients after intratumoral delivery of aolenoviral p53 (INGN 201 ) and radiation therapy[J]. Clin Cancer Res ,2003,9(1):93-101.
  • 6杨梅,汤致强.抗肿瘤药物的不良反应及防治措施[J].中国新药杂志,2008,17(21):1889-1893. 被引量:23
  • 7彭朝晖,张晓志.国外重组腺病毒-p53制品对肿瘤基因治疗临床研究的概况[J].中华医学杂志,2003,83(23):2098-2100. 被引量:37

二级参考文献43

  • 1陈生宏,钱爱华,张庆利.抗癌药物毒副作用的中药防治进展[J].临床荟萃,2001,16(1):42-43. 被引量:2
  • 2宋晓坤,戈秀云.抗肿瘤药所致皮肤损害及其防治[J].中国药房,2005,16(8):629-631. 被引量:2
  • 3王惠杰,张湘茹,王绿化.抗肿瘤药物的肺损伤[J].国外医学(肿瘤学分册),2005,32(5):391-394. 被引量:7
  • 4MUNOZ A, CARRERA S, FERREIRO J, et al. Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer[ J]. Ann Oncol, 2007,18(12) :2045 - 2046.
  • 5LIU V, WHITE DA,ZAKOWSKI MF,et al. Puhnonary toxicity associated with erlotinib [ J ]. Chest, 2007,132 ( 9 ) : 1042 - 1044.
  • 6COUDERC LJ,ANIDES S,FRACHON I,et al. Pulmonary toxicity of chemotherapy and G/GM-CSF: a report of five cases [ J ]. Respir Med, 1999,93 ( 1) :65 - 68.
  • 7SLIMACK N,KLINGE SA,SINGH V,et al. Gemcitabine-associated interstitial pneumonitis: Comprehensiveness and clinical characteristics of FDA and medical literature cases [ J ]. ASCO Meeting Abstracts, 2004,22 (14s) :7229.
  • 8WER MS,O'SHAUGHNESSY JA. Cardiac toxicity of trastuzumab-related regimens in HER2-overexpressing breast cancer [ J ]. Clin Breast Cancer, 2007,7 ( 8 ) :600 - 607.
  • 9KEOHAN M,D'ADAMO D,Q1N L,et al. Analysis of toxicity in a phase Ⅱ study of sorafenib in soft tissue sarcoma (STS)[ J]. ASCO Meeting Abstracts, 2007,25 (18s) : 10061.
  • 10KAPITEIJN E, BRAND A, KROEP J,et al. Sunitinib induced hypertension, thrombotic microangiopathy and reversible posterior leukencephalopathy syndrome [ J ]. Ann Oncol, 2007,18 ( 10 ) : 1745 - 1747.

共引文献58

同被引文献37

引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部